Latest update of the coronavirus vaccineTo avoid apprehensions about the availability of the coronavirus vaccine for everyone in the country, AIIMS Delhi Director Dr. Randeep Guleria said Thursday that it is not possible to vaccinate everyone in India at first. He added that there has to be a priority list to see who should get vaccinated first. Also read: No link between ‘serious adverse event’ suffered by Chennai participant and Oxford COVID vaccine, says DCGI
“At first, the vaccine will not be available in enough doses to give everyone. We need a priority list to make sure we vaccinate those who have a high chance of dying from Covid. The elderly, people with comorbidities and front-line workers should be vaccinated first, ”said Dr. Guleria. Also Read: Oxford-AstraZeneca Coronavirus Vaccine Results Probably Late January – Report
Saying that vaccines in India are in their final testing stage, he expressed hope that by the end of this month or early next, the country will obtain emergency use authorization from Indian regulatory authorities to begin administering the vaccinate the public. Also read: BioNtech and Pfizer request approval of the coronavirus vaccine in Europe, launch target in December
“There is good data available that vaccines are very safe. The safety and efficacy of the vaccine are not compromised at all. 70,000-80,000 volunteers received the vaccine, no significant serious adverse effects were observed. The data shows that the vaccine is safe in the short term, ”added Guleria.
He also added that they are working on a war footing both at the central and state levels for the vaccine distribution plan in terms of maintaining the cold chain, availability of adequate warehouses, development of strategies, training of vaccinators and availability of syringes.
“Once the booster dose is given, the vaccine will provide a good amount of antibody production and will begin to provide protection. This will last for many months and provide protection for a significant time when the numbers will be lower. We need to see the type of immunity that the vaccine provides, ”added Guleria.
Speaking of the current wave of coronavirus, he said that there is now a decline in the current wave and he expected this to continue if everyone is able to have a good appropriate COVID-19 behavior.
Giving details about the Chennai test case, he said it was an incidental finding rather than a vaccine-related one. “When we vaccinate a large number of people, some of them may have some other disease, which may not be related to the vaccine,” he said.
.
